SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-19-007909
Filing Date
2019-02-13
Accepted
2019-02-13 16:06:09
Documents
5
Effectiveness Date
2019-02-13

Document Format Files

Seq Description Document Type Size
1 S-8 a19-4519_1s8.htm S-8 124455
2 EX-5.1 a19-4519_1ex5d1.htm EX-5.1 11825
3 EX-23.2 a19-4519_1ex23d2.htm EX-23.2 3807
4 EX-99.1 a19-4519_1ex99d1.htm EX-99.1 95840
5 GRAPHIC g45191kmi001.jpg GRAPHIC 1191
  Complete submission text file 0001104659-19-007909.txt   238761
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-229643 | Film No.: 19597091
SIC: 2834 Pharmaceutical Preparations